LiberaCell™Cryopreservation System for Live Cell Therapies
LiberaCell™ is a hydrogel-based encapsulation platform designed to protect sensitive cells during freezing, storage, and shipping—without relying on liquid nitrogen. Its advanced structure minimizes freeze–thaw damage and enables “release-on-demand” recovery at the point of use, simplifying logistics and safeguarding cell functionality across the supply chain.
Primary Benefits of LiberaCell™
LiberaCell™ preserves therapeutic cell integrity during transport and storage.
Cells are released by adding a benign chemical trigger, enabling easy recovery at the point of use
Protects sensitive cells during shipping and storage without the need for liquid nitrogen. Enables dry ice or -20°C conditions, significantly reducing cold chain complexity and cost.
Minimizes mechanical and thermal stress, preserving cell viability and performance.
Real-World Applications
LiberaCell™ helps eliminate traditional cryo-barriers—offering flexibility, safety, and scalability in cold chain logistics.
Hepatocyte Spheroid Storage & Transport
In comparative studies, LiberaCell™ preserved higher viability and metabolic activity post-thaw versus unencapsulated or alginate-preserved samples.
Multi-Site Clinical Trials
Simplifies and standardizes frozen cell shipments across research and treatment sites without compromising performance.
“This study demonstrates LiberaCell’s ability to not only preserve fragile 3D liver spheroids, but also enhance their functional performance—transforming how complex cell models are stored, shipped, and scaled.”
Explore Other Cryopreservation & Logistics Solutions
Explore complementary platforms designed to simplify and strengthen biologic shipping and storage.
Let’s Collaborate
Interested in using LiberaCell™ for secure and scalable cell therapy transport? Let’s talk about custom logistics strategies, stability goals, and global distribution plans.